Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patients
2024

Study on Antibody Responses to SARS-CoV-2 Vaccination

Sample size: 87 publication 10 minutes Evidence: moderate

Author Information

Author(s): Patel Sara V., Leeman Brooke M., Botros Patricia J., Folta Joanna, Shahid Dhiman, Rocque Anya I., Joyal Andrew S., Vecchio Joseph A., Passell Eliza, Tien Dessie, Reynolds Zahra, Su Karry, Vyas Tammy D., Vyas Jatin M., Abar Emory, Barry Mamadou, Alexandrescu Andrew, Wallace Zachary, DaCosta Jeffrey M., Choudhary Manish C., Tamura Trevor, Edelstein Gregory, Li Yijia, Deo Rinki, Sparks Jeffrey A., Boucau Julie, Glover Owen, Barczak Amy, Lemieux Jacob, Siedner Mark J., Li Jonathan Z., Fofana Ismael Ben

Primary Institution: Boston College

Hypothesis

S2-specific antibody responses are suboptimal in vaccinated and SARS-CoV-2 infected patients resulting in an ineffective neutralization of distant coronaviruses.

Conclusion

S2-specific antibody responses are generally lower than S1-specific responses, but S2 responses correlate with neutralization in immunocompromised patients.

Supporting Evidence

  • S1-specific antibody responses were more abundant than S2-specific responses.
  • Immunocompetent individuals showed positive correlations between S1 and S2-specific antibody responses and pseudovirus neutralization.
  • Immunocompromised patients had lower overall antibody levels compared to immunocompetent individuals.

Takeaway

The study found that people vaccinated against COVID-19 have lower levels of certain antibodies that help fight off different types of coronaviruses, especially in those with weakened immune systems.

Methodology

The study analyzed S2-specific antibody responses in vaccinated and SARS-CoV-2 infected individuals, comparing neutralization capacities against various pseudoviruses.

Limitations

The study is limited by modest sample sizes, particularly among the immunocompromised sub-group, and lacks samples from vaccinated but non-infected participants.

Participant Demographics

The cohort included 87 participants, with 60 females and 27 males, including immunocompromised individuals.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.21203/rs.3.rs-5487774

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication